Videos
Theranostics Advances in Solid Tumors
03/19/2026
At Great Debates Solid Tumors in Miami, Florida, Scott Tagawa, MD, from Weill Cornell Medicine, New York, New York, discusses the principles and clinical applications of targeted radionuclide therapy in oncology.
Dr Tagawa reviews the evolution of theranostics from thyroid cancer to its current use in neuroendocrine and prostate cancers, highlighting the ability to both image and treat tumors based on target expression, and outlines opportunities and challenges in expanding this approach across additional tumor types.
Source:
Tagawa S. Radiopharmaceuticals in solid tumors: What every oncologist should know. Presented at Great Debates - Solid Tumors; Miami, Florida. March 14-15, 2026.
